Application of nicotinamide mononucleotide

A single nucleotide and nicotinamide technology, applied in the field of medicine, can solve the problems of insufficient effect, low safety, short treatment time, etc., and achieves the effect of wide treatment window, high safety, and prevention and treatment of cerebral apoplexy.
CN101601679AActive Publication Date: 2009-12-16SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
0 Cites 36 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Publication Date
2009-12-16

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses the application of nicotinamide mononucleotide on preparing medicines or health-care food for resisting neuronal cell injury cerebral apoplexy or oxygen-glucose deprivation. The invention also provides a novel medical composite which can effectively resist the neuronal cell injury caused by cerebral apoplexy and oxygen-glucose deprivation, thereby showing great significance to the treatment of cerebral apoplexy; and the active component in the medical composite is the nicotinamide mononucleotide which is an endogenic protective substance for an organic body and can not generate side effects according to current information, and therefore the nicotinamide mononucleotide used as a medicine has higher security and wide time window for treatment.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicine, and in particular relates to the application of nicotinamide mononucleotide in the preparation of drugs or health food for resisting cerebral stroke or neuron cell damage caused by hypoxia and glucose deficiency. Background technique

[0002] The pathogenesis of ischemic stroke is complex and seriously endangers human health. Therefore, seeking the ideal drug for stroke treatment has always been one of the research hotspots in the field of cardiovascular and cerebrovascular medicine. Thrombolytics and neuroprotective agents are the main drugs used in the treatment of stroke. The deficiencies of the existing stroke treatment drugs mainly lie in the short treatment time window, insufficient safety, and unreliable effect. Moreover, most of the drugs are considered from the aspect of reducing the damage factors produced after the occurrence of cerebral infarction, and few drugs are considered from the aspect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More